(Q33457676)

26 July 2017

title

A combined nutrient and lactulose challenge test allows symptom-based clustering of patients with irritable bowel syndrome (English)

1 reference

26 July 2017

main subject

irritable bowel syndrome

1 reference

1 reference

9

M Simrén

1 reference

26 July 2017

B Le Nevé

1

1 reference

26 July 2017

I Posserud

2

1 reference

26 July 2017

L Böhn

3

1 reference

26 July 2017

D Guyonnet

4

1 reference

26 July 2017

P Rondeau

5

1 reference

26 July 2017

K Tillisch

6

1 reference

26 July 2017

B Naliboff

7

1 reference

26 July 2017

E A Mayer

8

1 reference

26 July 2017

language of work or name

English

0 references

publication date

16 April 2013

1 reference

The American Journal of Gastroenterology

26 July 2017

published in

1 reference

26 July 2017

volume

108

1 reference

26 July 2017

issue

5

1 reference

26 July 2017

page(s)

786-795

1 reference

https://scigraph.springernature.com/pub.10.1038/ajg.2013.75

26 July 2017

exact match

0 references

cites work

Patient-reported outcomes and gut dysmotility in functional gastrointestinal disorders.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.75

Longitudinal change in perceptual and brain activation response to visceral stimuli in irritable bowel syndrome patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.75

Mechanisms of hypersensitivity in IBS and functional disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.75

Intestinal membrane permeability and hypersensitivity in the irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.75

Alterations in mucosal immunity identified in the colon of patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.75

Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.75

Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.75

Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.75

Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.75

Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.75

The brain-gut axis in abdominal pain syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.75

Neuroimaging of the brain-gut axis: from basic understanding to treatment of functional GI disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.75

Intestinal microbiota in functional bowel disorders: a Rome foundation report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.75

Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.75

The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.75

Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome--a longitudinal study in IBS and control subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.75

Ulcerative colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.75

An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.75

The effect of a nonabsorbed oral antibiotic (rifaximin) on the symptoms of the irritable bowel syndrome: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.75

Rifaximin therapy for patients with irritable bowel syndrome without constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.75

A randomized double-blind placebo-controlled trial of rifaximin in patients with abdominal bloating and flatulence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.75

The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.75

Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.75

Functional GI disorders: from animal models to drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.75

Abnormal colonic fermentation in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.75

Impaired transit and tolerance of intestinal gas in the irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.75

In vivo and transgenic animal models used to study visceral hypersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.75

Efficacy and safety of traditional medical therapies for chronic constipation: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.75

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.75

Perceived food intolerance in subjects with irritable bowel syndrome-- etiology, prevalence and consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.75

Small intestinal bacterial overgrowth in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.75

Lactulose breath testing does not discriminate patients with irritable bowel syndrome from healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.75

Prospective, randomized, parallel-group trial to evaluate the effects of lactulose and polyethylene glycol-4000 on colonic flora in chronic idiopathic constipation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.75

The hospital anxiety and depression scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.75

The Visceral Sensitivity Index: development and validation of a gastrointestinal symptom-specific anxiety scale.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.75

The central role of gastrointestinal-specific anxiety in irritable bowel syndrome: further validation of the visceral sensitivity index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.75

Gastrointestinal-specific anxiety: an important factor for severity of GI symptoms and quality of life in IBS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.75

Functional bowel disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.75

Relationship of abdominal bloating to distention in irritable bowel syndrome and effect of bowel habit

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.75

Microbes and the gut-brain axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.75

Beneficial psychological effects of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in healthy human volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.75

Small intestinal bacterial overgrowth in irritable bowel syndrome: association with colon motility, bowel symptoms, and psychological distress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.75

Impaired viscerosomatic reflexes and abdominal-wall dystony associated with bloating

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.75

Accommodation of the abdomen to its content: integrated abdomino-thoracic response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.75

Bloating and distention in irritable bowel syndrome: the role of visceral sensation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.75

Expression of the short-chain fatty acid receptor, GPR43, in the human colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.75

Short-chain fatty acids regulate the enteric neurons and control gastrointestinal motility in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.75

Quality of life in patients with irritable bowel syndrome seen in referral centers versus primary care: the impact of gender and predominant bowel pattern.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.75

21 January 2018

Identifiers

DOI

10.1038/AJG.2013.75

1 reference

Dimensions Publication ID

26 July 2017

1050477925

0 references

1 reference